Meridien Research Site# 108 — Tampa, Florida

Meridien Research Site# 108 is a clinical research site located in Tampa, Florida, United States 33634.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Meridien Research Site# 108 has participated in 1 clinical trials.

Therapeutic areas: Neurobehavioral Disinhibition.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Meridien Research Site# 108?

Meridien Research Site# 108 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Meridien Research Site# 108 conducted?

Meridien Research Site# 108 has 1 clinical trials on record. Their work covers Neurobehavioral Disinhibition.

Is Meridien Research Site# 108 accredited by Crixeo Health?

Meridien Research Site# 108 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Meridien Research Site# 108?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.